CRA Annual Scientific Meeting 2018-09-13T18:10:36+00:00

2019 CRA Annual Scientific Meeting & AHPA Annual Meeting

Important Dates

Abstract Submission Opens  August 13, 2018
Abstract Submission Deadline October 12, 2018
Membership Registration Opens late November 2018
ASM Registration Opens  late November 2018
Early-Bird ASM Registration Closes  January 10, 2019
ASM Registration Closes January 24, 2019
Early-Bird Membership Registration Closes January 31, 2019

Building Bridges

Bridges bring together lands, ideas, cultures, and friends, strengthening our understanding of others and creating opportunities for growth and prosperity. These are only a few of the many reasons we have chosen to highlight “Building Bridges” as the theme of the CRA’s 2019 Annual Scientific Meeting. It is fitting that the ASM will be held in Montreal, QC against the backdrop of the Jacques Cartier bridge, so-named in 1934 on the 400th anniversary of Jacques Cartier’s voyage up the St. Lawrence River.

In addition to the Distinguished Investigator lecture that will be announced in the coming months, the 2019 ASM will feature 3 keynote addresses by internationally recognized figures including the Globe and Mail’s André Picard, myopathy expert and neuromuscular specialist Dr. Mark Roberts from Manchester, UK, and the CRA’s own Dr. Gilles Boire from Sherbrooke, QC will give the 2019 Dunlop-Dottridge Lecture.

Dr. Mark Roberts will speak about Neurology working together with Rheumatology, and myositis and its mimics. Dr. Roberts is a Consultant Neurologist at the Greater Manchester Neurosciences Unit at Salford Royal NHS Foundation Trust, with additional clinical commitments at the Royal Manchester Childrens Hospital, University Hospital of South Manchester and Withington Community Hospitals. He was a research fellow to Professors Newsom-Davis and Angela Vincent at the Institute of Molecular Medicine in Oxford from 1993 to 1996 and has published widely on neuromuscular disease. In 2000 he was appointed as consultant neurologist in Manchester and commenced his private practice that same year. He has extensive experience in general neurology including epilepsy, parkinson’s disease, multiple sclerosis and neuromuscular disorders.

Professor Gilles Boire began his career with some important observations in the field of autoimmunity (antigen-antibody system linked to ribonucleoprotein Ro). These experiments led to the discovery of the anti-Sa autoantibody, specific to rheumatoid arthritis. This led him to establish in 1997 a longitudinal cohort of patients with newly established inflammatory arthritis. Dr. Boire’s work has contributed extensively to the understanding of autoimmunity, biomarkers and psychosocial determinants in clinical outcomes in recent-onset inflammatory arthritis, and secondary prevention of bone fragility fractures. He is Professor of Rheumatology in the Department of Medicine at the Université de Sherbrooke, with affiliations in the Departments of Biochemistry, Immunology, and Pediatrics. The Dunlop-Dottridge Lecture was created to highlight significant career achievements in Rheumatology and we are delighted to celebrate Dr. Boire’s achievements with this honour.

André Picard, who lives in Montréal, is one of Canada’s top health and public policy observers and commentators. He is the health columnist at The Globe and Mail, where he has been a staff writer for more than 30 years. He is also the author of numerous books and has received much acclaim for his writing and for his dedication to improving healthcare. In 2010, he was awarded a National Newspaper Award as Canada’s top newspaper columnist, the Canadian version of the Pulitzer Prize. Monsieur Picard will speak to the future and evolution of the Canadian health system and implications for the future of Rheumatology.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Rheumatology Association.

AMA PRA Category 1

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

UEMS

Live educational activities, occurring in Canada, recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC®.

Abstract Submission deadline is October 12, 2018 at 23:59 PT

Attendees at the 2019 Canadian Rheumatology Association (CRA) Annual Scientific Meeting (ASM) and the Arthritis Health Professions Association (AHPA) Annual Meeting are invited to submit abstracts for presentation during the meeting. We encourage you to submit abstracts relating to original research, systematic reviews or meta-analyses. Case reports or case series are acceptable. Project proposals without data or results will not be accepted. Abstracts may be presented at one meeting prior to the CRA ASM but data cannot be published before the CRA ASM. Abstracts cannot be submitted on data that has already been accepted for publication as a manuscript (publication in abstract form from a conference presentation is acceptable).

Abstract Submission/Guidelines

What are Clinical Pearls?

Short, practical medical tips submitted by readers that may not be widely known but can be used to solve everyday clinical problems. Pearls derive from patient-centered observations and should be applicable to other patients.

What are Mysterious Cases?

Your particularly puzzling clinical case presented either as a short (10-15 minutes) video, picture or description.

Dunlop-Dottridge Lecture

Dr. Boire is a Professor in the Division of Rheumatology of the Faculty of Medicine and Health Sciences at the Université de Sherbrooke. Dr. Boire practices both adult and pediatric rheumatology at the Centre intégré universitaire de santé et de services sociaux de l’Estrie – Centre hospitalier universitaire de Sherbrooke (CIUSSSE-CHUS).

Dr. Boire is a graduate from the Université of Montréal (BSc Chemistry, 1975) and from the Université de Sherbrooke (MD, 1981; MSc Clinical Sciences 1991). He obtained his certification in Internal Medicine (1985), then in Rheumatology (1986) and completed his postdoctoral training at the Université de Sherbrooke (1986-87) and at Yale University (1987-89).

Dr. Boire’s major research interests are in the area of autoimmunity, in particular the Ro/hY RNA complex and in the characterization of biomarkers and other predictors useful for the early prognostic classification of patients with recent onset inflammatory arthritis. He initiated in 1997 the still ongoing Early Undifferentiated Polyarthritis (EUPA) cohort of patients with recent-onset polyarthritis. He is one of the founding members and currently Director of Ethical Scientific Conduct of the Canadian Early Arthritis Cohort (CATCH), a pan-Canadian cohort of patients with recent onset inflammatory arthritis. Together with an orthopaedist colleague, Dr. François Cabana, in January 2007 he initiated the OPTIMUS initiative, prompting primary care practitioners to evaluate and treat osteoporosis revealed by fragility fractures following their identification in orthopedists’ clinics in the hope of improving rates of long term appropriate therapy.

Since 1990, his research has been continuously supported, by The Arthritis Society, the Medical Research Council (MRC) and the Canadian Institutes of Health Research (CIHR), the Fonds pour la recherche en santé du Québec (FRSQ), the Fonds d’aide aux chercheurs et à la recherche (FCAR), the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Initiative for Outcomes in Rheumatology Care (CIORA). During that period, Dr. Boire supervised 18 graduate students and trained 19 rheumatology fellows. Dr. Boire is involved in a number of clinical and fundamental research projects and is the author of 127 peer-reviewed publications.

Keynote Lecture

André Picard is the health columnist at The Globe and Mail and the author of five books, including Matters of Life and Death: Public Health Issues in Canada, and The Path to Health Care Reform: Policies and Politics. He also has a large Twitter following at @picardonhealth.

André has received much acclaim for his writing, including the Michener Award for Meritorious Public Service Journalism and the Centennial Prize of the Pan-American Health Association, awarded to the top health journalist in the Americas.  He is also an eight-time finalist for the National Newspaper Awards – Canada’s version of the Pulitzer Prize.

He is a seasoned communicator who employs a conversational style to reach his audience. He enlivens his research and commentary with personal stories to provide context for his audience, including anecdotes from patients and health professionals the front lines.

André will enlighten and pique a sense of curiosity of audience members from all educational backgrounds. His work as one of North America’s top health journalists reflects his personality: Behind the placid exterior lies an inquisitive, perceptive and industrious scribe for whom the work only begins with the off­icial story.

André is a graduate of the University of Ottawa and Carleton University, and has received honourary doctorates from six universities, including the University of Toronto, UBC and the University of Manitoba.

State of the Art Lecture

Dr. Roberts read Medicine and Physiology at the University of Liverpool qualifying in 1989 developing an interest in the neurological control of the gut.  As a junior doctor in 1990 he studied Medicine in Manchester, before in 1992 moving to the National Hospital for Neurology in London and working for Prof. PK Thomas and Anita Harding he became more interested in neuromuscular and multisystem disorders.

In 1993 he was a Research Registrar at the Institute of Molecular Medicine Oxford where he studied for 3 years with Prof. John Newsom-Davis and Angela Vincent, into the immune mechanisms in peripheral neuropathies. In  1996 he moved back to Liverpool as a Clinical Registrar in neurology, with additional electives in Durban and London. In 2000, he was appointed a Consultant in Neurology in Manchester specialising in Neuromuscular Disease (NMD), and transitional care. In 2001 with Prof Woodcock he developed a neuromuscular  ventilatory support service for patients with Duchenne Muscular Dystrophy and related disorders, and began to see increasing numbers of patients with inherited metabolic disorders (IMD). The North West Ventilatory Service is now the largest in the UK seeing over 2000 patients annually.

In 2002 he established the North West Neumuscular Network with paediatric colleagues, awarded National Centre of Excellence status in 2017.  In 2005, he joined Dr. Steven Waldek in the Metabolic clinic at Salford, Manchester to care patients with IMD. Since 2010 with Prof Chris Hendriksz he has developed Neurometabolic services in the North West of England, now his major clinical and research interest. Since 2013 his PhD Clinical fellow Dr. Fanea has studied metabolic causes of Psychosis in a multidisciplinary project between Neurology, Psychiatry and Metabolic Medicine. In 2017 he was appointed Clinical Lead in Adult Metabolic Disorders at Salford, the largest Unit in Europe.

His current research focuses on clinical phenotypes and identification of neuromuscular disorders, IMD and liaison with other specialities including Respiratory Medicine and especially Rheumatology. Since 2002 he has done a weekly joint clinic with Dr. Hector Chinoy at Salford, to provide patients with a joint Neurology and Rheumatology opinion, this attracts local and National referrals and patients have clinical, EMG examination as needed muscle biopsy. In 2014 Dr. Chinoy and Roberts co-supervised Dr. Lilleker PhD on Inclusion Body Myositis. He has lectured and published widely on IMD, NMD and other Neurological disorders, and is a regular presenter at The British Rheumatology Society. He is considered a National expert in Metabolic Myopathies and Muscular Dystrophy.

Fairmont The Queen Elizabeth

900 Rene Levesque Blvd. W
Montreal, Quebec
1 514 861 3511

Room

Rate

Fairmont Room $205.00
Fairmont View Room $235.00
Junior Suite $305.00
Fairmont Gold Room $325.00
One-Bedroom Suite $485.00
  • Rates are guaranteed in Canadian Funds.
  • Hotel room rates are subject to applicable provincial and local taxes and fees (currently 18.475%) in effect at the time of check-out.
  • All reservations must be guaranteed with a major credit card.
  • A non-refundable deposit equal to a one night stay will be charged at the time of booking.
  • Cancellations made up to 48 hours prior to arrival will be accepted and no charges or penalties will be incurred outside of the non-refundable deposit equal to one night’s stay.
  • Complimentary high speed internet access in all hotel bedrooms, meeting rooms and conference space.
  • A completely redesigned Wellness Centre and indoor pool.
  • The maximum occupancy per room is 4 persons.
  • Self-parking is located on the South side of Belmont street (fees must be paid directly at the parking terminals).
  • Valet-parking is an additional $35/day.

Check-in and Early Departure

The Hotel’s check-in and check-out time are 4:00 pm and 12:00 pm respectively.  Guests are permitted to check out later subject to room availability (a late departure fee may be applicable).  Guests will be charged an Early Departure Fee of $102.50 if they depart prior to their confirmed departure date (guests can change their departure date to an earlier date without charge up to and including the time of registration).

Reservations

Reservations can be made by using the online reservation link which will be available in November. Reservations must be made prior to Friday, January 25, 2019. After that date, reservations will be subject to prevailing rates and availability.

Tuesday, February 26, 2019

19:30-onwards Residents’ Reception
19:30-onwards AHPA Reception 

Wednesday, February 27, 2019

08:00-15:30 AHPA Pre-Course
08:00-15:30 Residents’ Pre-Course 
08:00-15:30 Committee & Small Group Meetings/Networking/Free Time
15:00-16:00 Mentor Program Reception 
Open to mentors and mentees only
15:00-16:00 Summer Student Reception
Open to summer students, mentors, Pfizer and Novartis reps only
15:00-16:00 Career Fair 
16:15-16:20

Welcome Address

Vandana Ahluwalia & Tom Appleton

16:20-17:15 Clinical Pearls and Mysterious Cases
17:15-18:00 National Update
18:00-18:15 Arthritis Society Update
18:30-19:30

Keynote Lecture by Andre Picard: Future of Medicine/State of the Health System

19:30 onwards Welcome Reception 

Thursday, February 28, 2019

07:00-08:15 Breakfast (only available to attendees of unaccredited symposium)
08:45-10:00 *Podium Presentations
10:00-11:00

State of the Art Lecture by Mark Roberts: Mimics of Myositis: A MDT Approach

11:15-12:15

Workshop Session 1

TBD
TBD
TBD
12:15-13:30 Lunch (only available to attendees of unaccredited symposium) 
13:30-15:45 Committee & Small Group Meetings/Networking/Free Time
15:15-17:15 Poster Session
15:15-17:15 Meet the Expert Session 
17:30-18:30

Great Debate

Friday, March 1, 2019

07:00-08:15 Breakfast (only available to attendees of unaccredited symposium)
08:45-10:00 *Podium Presentations
10:15-11:15

Workshop Session 2

11:30-12:30

Keynote Address by Distinguished Investigator Awardee 2019

12:30-14:15 CRA Lunch and AGM 
CRA members only
14:30-15:30 Rheumjeopardy
15:45-17:45 Poster Session
15:45-17:45 Meet the CRA Expert Session
17:45-19:00 Committee & Small Group Meetings/Networking/Free Time
19:00-onwards Reception, Gala Dinner, Awards & Dance 
Dress code is business formal

Saturday, March 2, 2019

07:00-08:15 Breakfast 
08:45-09:45

Dunlop-Dottridge Lecture by Gilles Boire: Discovery of Serum Biomarkers

10:00-11:00

Workshop Session 3

11:15-12:15 CIORA Project Showcase
12:15-12:20 Closing Address